Temporal Trends and Disparities in Hypertension‐Related Cardiomyopathy Mortality in the United States, 1999–2023
Clinical Cardiology · 2026-07 · 49 (7)
DOI: 10.1002/clc.70417 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Cardiology, online erschienen am 17.07.2026. Verfasst von Javeria Akhter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lung Health Program, Community Health Directorate, Indus Hospital and Health Network, Karachi, Pakistan. Hauptthemen laut MEDLINE: Hypertension, Cardiomyopathies, Health Status Disparities. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hypertension and cardiomyopathy are major contributors of cardiovascular morbidity in the United States. This study investigates long‐term mortality trends and disparities in hypertension‐related cardiomyopathy from 1999 to 2023 in the United States.
Methods
Mortality data from CDC WONDER (1999–2023) were evaluated for cardiomyopathy (ICD‐10 I42, I42.2, and I42.9) as the primary cause of death and hypertension (ICD‐10 I10, I15.0 and I15.9) as a contributing cause among individuals aged ≥ 25 years. Age‐adjusted mortality rates (AAMRs) were standardized to the United States 2000 population. Joinpoint regression estimated annual percent change (APC) with 95% confidence intervals.
Results
Between 1999 and 2023, 153 563 deaths were identified. AAMR increased from 1.26 per 100 000 in 1999 to 2.22 in 2023, driven by a significant early rise from 1999 to 2001 (APC: +30.33; p < 0.005). Males had higher mortality than females (2.98 vs. 1.61) with males declining significantly from 2001 to 2023 (APC: −0.64; p < 0.005). NH Black individuals had the highest AAMR (10.81), followed by NH White individuals (5.02). Mortality was higher in non‐metropolitan than metropolitan areas (2.71 vs. 2.26), both declining significantly after 2001 (APC: −0.89; −1.69; p < 0.005). South had the highest burden (AAMR: 4.86), while the Midwest rose significantly after 2017 (APC: +4.11; p < 0.005). Adults aged ≥ 85 years had the highest mortality (CMR: 32.79) increasing significantly after 2015 (APC: +2.44 p < 0.005).
Conclusion
Hypertension‐related cardiomyopathy mortality rose sharply in 1999–2001 before declining through 2023, with persistent disparities by sex, race, geography, and age. Targeted hypertension control and equitable cardiovascular care remain needed to reduce this burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lung Health Program, Community Health Directorate, Indus Hospital and Health Network, Karachi, Pakistan.
- Jinnah Sindh Medical University, Karachi, Pakistan.
- Khairpur Medical College, Khairpur, Pakistan.
- School of Medicine, University of Jordan, Amman, Jordan.
- Department of Medicine, Lebanese University, Beirut, Lebanon.
ORCID-Profile: Javeria Akhter, Muhammad Umar, Jamil Nasrallah
Zitieren
APA
Akhter, J., Taj, I., Umar, M., Khatib, A. N. A., & Nasrallah, J. (2026). Temporal Trends and Disparities in Hypertension‐Related Cardiomyopathy Mortality in the United States, 1999–2023. Clinical Cardiology, 49(7). https://doi.org/10.1002/clc.70417
Vancouver
Akhter J, Taj I, Umar M, Khatib ANA, Nasrallah J. Temporal Trends and Disparities in Hypertension‐Related Cardiomyopathy Mortality in the United States, 1999–2023. Clinical Cardiology. 2026;49(7). doi:10.1002/clc.70417
BibTeX
@article{Akhter2026,
author = {Akhter, Javeria and Taj, Iqra and Umar, Muhammad and Khatib, Abdulrahman Nasir Al and Nasrallah, Jamil},
title = {Temporal Trends and Disparities in Hypertension‐Related Cardiomyopathy Mortality in the United States, 1999–2023},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {7},
doi = {10.1002/clc.70417}
}
EUVIMED